Cytomegalovirus (CMV) Tests Market Size by Segments, Share, Regulatory and Reimbursement, Procedures and Forecast to 2033
Cytomegalovirus (CMV) Tests Market Report Overview
The Cytomegalovirus (CMV) Tests market size was valued at $43.8 million in 2022. Chlamydia is a common sexually transmissible disease, caused by the bacteria Cytomegalovirus (CMV). In women, Cytomegalovirus (CMV) infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic pregnancy, and chronic pelvic pain.
Cytomegalovirus (CMV) Tests Market Outlook 2022-2033 ($ Million)
For more insights on the Cytomegalovirus (CMV) Tests market forecast, download a free sample report
The Cytomegalovirus (CMV) Tests market research report is built to visualize quantitative market trends within in vitro diagnostics therapeutic areas. Furthermore, the model discusses in detail the impact of COVID-19 on the Cytomegalovirus (CMV) Tests market for the year 2020 and beyond.
| Market Size (2022) | $43.8 million |
| Historic Period | 2015-2022 |
| Forecast Period | 2023-2033 |
| Key Segments |
|
| Key Regions |
|
| Key Companies |
|
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Cytomegalovirus (CMV) Tests Market Dynamics
Cytomegalovirus (CMV) is a widely distributed pathogen that causes congenital infection worldwide. It is a human herpesvirus that can be transmitted through intimate contact with infected bodily fluids and through transplacental transfer, blood transfusion, or organ transplantation. The market is projected to recover and have minimal growth post-COVID-19 impacted years. The latter growth is being driven by several factors such as increases in the number of immunocompromised cases and sperm donations. Sales of these devices are also impacted by fluctuations in live birth rates, which heavily influence diagnostic and screening tests performed for both pregnant women and neonates. Additionally, there are multiple ongoing clinical studies aimed at discovering potential vaccines for CMV, as well as antiviral medicines to reduce transmission. These have the potential to strongly impact the CMV Tests market.
For additional Cytomegalovirus (CMV) Tests market dynamics, download a free sample report
Cytomegalovirus (CMV) Tests Market Segments
The key segments in the Cytomegalovirus (CMV) Tests market are Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests, Nucleic Acid Amplification Tests (NAATs), and Other Cytomegalovirus (CMV) test kits. In 2022, the Nucleic Acid Amplification Tests (NAATs) segment dominated the market share. NAAT devices are also sometimes employed for the diagnosis of CMV infection. Additionally, these tests are often used as confirmatory tests or to perform CMV viral load testing in immunocompromised or transplant patients.
Cytomegalovirus (CMV) Tests Market Analysis by Segments, 2022 (%)
To know more about the Cytomegalovirus (CMV) Tests market segments, download a free sample report
Cytomegalovirus (CMV) Tests Market Segmentation by Regions
The key regions in the Cytomegalovirus (CMV) Tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2022, North America emerged as the leading regional segment with the US being the largest contributor to the regional market. The CMV tests market is expected to decline in North America during the forecasted years as countries try to recover from the drastic drop in CMV sales due to COVID-19. Additionally, the number of prenatal cases of CMV are declining in the USA as prenatal screening and diagnostic tests are being integrated into prenatal care.
Cytomegalovirus (CMV) Tests Market Analysis by Regions, 2022 (%)
For more regional insights in the Cytomegalovirus (CMV) Tests market, download a free sample report
Cytomegalovirus (CMV) Tests Market – Competitive Landscape
The key companies in the Cytomegalovirus (CMV) Tests market are Abbott Laboratories, StatLab Medical (SLMP), Danaher Corp,MBL International Corporation, bioMerieux SA, Bio-Rad Laboratories Inc, DiaSorin SpA, Erba Diagnostics Mannheim GmbH, Immucor Inc, Luminex Corp, E. Merck KGaA, Qiagen NV, Quidelortho Corp, Altona Diagnostic GmbH, F. Hoffmann-La Roche Ltd, Siemens AG, and Trinity Biotech Plc., among others. In 2022, Roche Diagnostics International Ltd accounted for the highest Cytomegalovirus (CMV) Tests market share and value.
Cytomegalovirus (CMV) Tests Market Analysis by Companies, 2022 (%)
For more company insights into the Cytomegalovirus (CMV) Tests market, download a free sample report
Segments Covered in this Report
Cytomegalovirus (CMV) Tests Segment Outlook ($ Million, 2015-2033)
- Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests
- Nucleic Acid Amplification Tests (NAATs)
- Other Cytomegalovirus (CMV) test kits
Cytomegalovirus (CMV) Tests Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
Key Inclusions of the market model are –
Currently marketed Cytomegalovirus (CMV) Tests market and evolving competitive landscape –
- Insightful review of the key industry trends.
- Annualized total Cytomegalovirus (CMV) Tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional and Country level market specific insights –
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Cytomegalovirus (CMV) Tests market.
- Competitive dynamics insights and trends provided for the Cytomegalovirus (CMV) Tests market.
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, StatLab Medical (SLMP), Danaher Corp,MBL International Corporation, bioMerieux SA, Bio-Rad Laboratories Inc, DiaSorin SpA, Erba Diagnostics Mannheim GmbH, Immucor Inc, Luminex Corp, E. Merck KGaA, Qiagen NV, Quidelortho Corp, Altona Diagnostic GmbH, F. Hoffmann-La Roche Ltd, Siemens AG, Trinity Biotech Plc., and Others.
Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for
- CMO executives who must have a deep understanding of the Cytomegalovirus (CMV) Tests marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to –
- Understand the impact of COVID-19 on Cytomegalovirus (CMV) Tests.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving Cytomegalovirus (CMV) Tests.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Cytomegalovirus (CMV) Tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Cytomegalovirus (CMV) Tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Key Players
Frequently Asked Questions
The Cytomegalovirus (CMV) Tests market size was $43.8 million in 2022.
Nucleic Acid Amplification Tests (NAATs) segment was leading the Cytomegalovirus (CMV) Tests market in 2022.
North America was the largest regional segment of the Cytomegalovirus (CMV) Tests market in 2022.
The key companies in the Cytomegalovirus (CMV) Tests market are Abbott Laboratories, StatLab Medical (SLMP), Danaher Corp,MBL International Corporation, bioMerieux SA, Bio-Rad Laboratories Inc, DiaSorin SpA, Erba Diagnostics Mannheim GmbH, Immucor Inc, Luminex Corp, E. Merck KGaA, Qiagen NV, Quidelortho Corp, Altona Diagnostic GmbH, F. Hoffmann-La Roche Ltd, Siemens AG, and Trinity Biotech Plc., among others.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
